Nader Sanai

18.4k total citations · 6 hit papers
192 papers, 12.8k citations indexed

About

Nader Sanai is a scholar working on Genetics, Epidemiology and Neurology. According to data from OpenAlex, Nader Sanai has authored 192 papers receiving a total of 12.8k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Genetics, 50 papers in Epidemiology and 47 papers in Neurology. Recurrent topics in Nader Sanai's work include Glioma Diagnosis and Treatment (102 papers), Meningioma and schwannoma management (48 papers) and Vascular Malformations Diagnosis and Treatment (18 papers). Nader Sanai is often cited by papers focused on Glioma Diagnosis and Treatment (102 papers), Meningioma and schwannoma management (48 papers) and Vascular Malformations Diagnosis and Treatment (18 papers). Nader Sanai collaborates with scholars based in United States, France and Spain. Nader Sanai's co-authors include Mitchel S. Berger, Arturo Álvarez-Buylla, Zaman Mirzadeh, Andrew T. Parsa, Mei‐Yin C. Polley, Michael W. McDermott, Alfredo Quiñones‐Hinojosa, José Manuel García‐Verdugo, Michael T. Lawton and Nalin Gupta and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Nader Sanai

184 papers receiving 12.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An extent of resection threshold for newly diagnosed glioblastomas

2011 1.2k citations Nader Sanai, Mitchel S. Berger et al. profile →
Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration

2004 989 citations Nader Sanai, Alfredo Quiñones‐Hinojosa et al. profile →
GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME

2008 967 citations Nader Sanai, Mitchel S. Berger Neurosurgery profile →
Neural Stem Cells and the Origin of Gliomas

2005 810 citations Nader Sanai, Arturo Álvarez-Buylla et al. New England Journal of Medicine profile →
Functional Outcome after Language Mapping for Glioma Resection

2008 748 citations Nader Sanai, Zaman Mirzadeh et al. New England Journal of Medicine profile →
Corridors of migrating neurons in the human brain and their decline during infancy

2011 650 citations Nader Sanai, Zaman Mirzadeh et al. profile →

Peers

Countries citing papers authored by Nader Sanai

Since Specialization

Citations

This map shows the geographic impact of Nader Sanai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nader Sanai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nader Sanai more than expected).

Fields of papers citing papers by Nader Sanai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nader Sanai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nader Sanai. The network helps show where Nader Sanai may publish in the future.

Co-authorship network of co-authors of Nader Sanai

This figure shows the co-authorship network connecting the top 25 collaborators of Nader Sanai. A scholar is included among the top collaborators of Nader Sanai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nader Sanai. Nader Sanai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An early clinical trial of 5-ALA sonodynamic therapy in recurrent high-grade glioma 2025 ·Science Translational Medicine ·Nader Sanai, Artak Tovmasyan, An‐Chi Tien, Yu‐Wei Chang, (unknown), (unknown), (unknown), Jennifer Eschbacher, (unknown), (unknown), Wonsuk Yoo, Charuta G. Furey, Stuart L. Marcus, Lea Alhilali, Igor J. Barani, Zaman Mirzadeh, Shwetal Mehta	0
2	A phase 0/1 trigger trial of BDTX-1535 in patients with recurrent high-grade glioma (HGG) with EGFR alterations or fusions. 2024 ·Journal of Clinical Oncology ·Nader Sanai, Yoshie Umemura, (unknown), (unknown), (unknown), (unknown), Amy Hong, Wonsuk Yoo, An‐Chi Tien, Artak Tovmasyan, Shwetal Mehta	1
3	Introduction: Contemporary management of low-grade gliomas: from tumor biology to the patient’s quality of life 2024 ·Neurosurgical FOCUS ·Hugues Duffau, Mitchel S. Berger, Priscilla K. Brastianos, Nader Sanai, Emmanuel Mandonnet, Guy M. McKhann	1
4	Mechanistic Modeling of Spatial Heterogeneity of Drug Penetration and Exposure in the Human Central Nervous System and Brain Tumors 2024 ·Clinical Pharmacology & Therapeutics ·Jing Li, (unknown), Jun Jiang, (unknown), (unknown), Artak Tovmasyan, Seongho Kim, Nader Sanai	2
5	The impact of intraoperative mapping during re-resection in recurrent gliomas: a systematic review 2024 ·Journal of Neuro-Oncology ·(unknown), (unknown), (unknown), Jacob S. Young, Sandro M. Krieg, Sebastian Ille, Nader Sanai, Jordina Rincón-Torroella, Takashi Maruyama, Philippe Schucht, Timothy R. Smith, Brian V. Nahed, Marike L. D. Broekman, Steven De Vleeschouwer, Mitchel S. Berger, Arnaud J.P.E. Vincent, Jasper K W Gerritsen	3
6	A Combined Phase 0/2 "Trigger" Trial Evaluating Pamiparib or Olaparib with Concurrent Radiotherapy in Patients with Newly-Diagnosed or Recurrent Glioblastoma 2023 ·International Journal of Radiation OncologyBiologyPhysics ·William R. Kennedy, Yun‐Woo Chang, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michael A. Garcia, Igor J. Barani, Wonsuk Yoo, (unknown), An‐Chi Tien, J. Li, Shwetal Mehta, Nader Sanai	4
7	CTNI-25. A PHASE 0/1B STUDY OF AZD1390 PLUS RADIOTHERAPY IN RECURRENT GLIOBLASTOMA PATIENTS 2023 ·Neuro-Oncology ·Nader Sanai, (unknown), (unknown), (unknown), (unknown), Jennifer K. Molloy, (unknown), Amy Hong, (unknown), John E. Wanebo, (unknown), (unknown), (unknown), Wonsuk Yoo, Artak Tovmasyan, An‐Chi Tien, Shwetal Mehta	0
8	347MO 5-Aminolevulinic acid sonodynamic therapy in recurrent glioblastoma: A first-in-human phase 0/1 clinical trial 2021 ·Annals of Oncology ·Nader Sanai, (unknown), (unknown), (unknown), (unknown), K Hendrickson, Jennifer Eschbacher, Wonbeak Yoo, John W. Harmon, (unknown), Lea Alhilali, Igor J. Barani, (unknown), Zaman Mirzadeh	1
9	Phase 0 and window of opportunity clinical trial design in neuro-oncology: a RANO review 2020 ·Neuro-Oncology ·Michael A. Vogelbaum, Daria Krivosheya, Hamid Borghei‐Razavi, Nader Sanai, Michael Weller, Wolfgang Wick, Riccardo Soffietti, David A. Reardon, Manish K. Aghi, Evanthia Galanis, Patrick Y. Wen, Martin J. van den Bent, Susan M. Chang	42
10	A Phase 0 Trial of Ribociclib in Recurrent Glioblastoma Patients Incorporating a Tumor Pharmacodynamic- and Pharmacokinetic-Guided Expansion Cohort 2019 ·Clinical Cancer Research ·An‐Chi Tien, Jing Li, Xun Bao, (unknown), Seongho Kim, Shwetal Mehta, Nader Sanai	55
11	Phase 0 Trial of AZD1775 in First-Recurrence Glioblastoma Patients 2018 ·Clinical Cancer Research ·Nader Sanai, Jing Li, Julie L. Boerner, (unknown), Jianmei Wu, Seongho Kim, (unknown), Shwetal Mehta, Harshil Dhruv, Lance K. Heilbrun, Michael E. Berens, Patricia LoRusso	61
12	Preoperative Embolization of Skull Base Meningiomas: Outcomes in the Onyx Era 2018 ·World Neurosurgery ·Colin J. Przybylowski, Jacob F. Baranoski, Alfred P. See, Bruno C. Flores, Rami O. Almefty, Dale Ding, Kristina Chapple, Nader Sanai, Andrew F. Ducruet, Felipe C. Albuquerque	20
13	Quantitative and Mechanistic Understanding of AZD1775 Penetration across Human Blood–Brain Barrier in Glioblastoma Patients Using an IVIVE–PBPK Modeling Approach 2017 ·Clinical Cancer Research ·Jing Li, Jianmei Wu, Xun Bao, Norissa Honea, Youming Xie, Seongho Kim, Alex Sparreboom, Nader Sanai	45
14	Surgical Management of Incidental Gliomas 2017 ·Neurosurgery Clinics of North America ·Imran Noorani, Nader Sanai	12
15	The value of extended glioblastoma resection: Insights from randomized controlled trials 2013 ·Surgical Neurology International ·(unknown), (unknown), Peter C. Warnke, Nader Sanai, (unknown), (unknown)	11
16	Advanced Technical Skills Are Required for Microsurgical Clipping of Posterior Communicating Artery Aneurysms in the Endovascular Era 2012 ·Neurosurgery ·Nader Sanai, (unknown), Dario J. Englot, Michael T. Lawton	42
17	Intraoperative stimulation techniques for functional pathway preservation and glioma resection 2010 ·Neurosurgical FOCUS ·Nader Sanai, Mitchel S. Berger	160
18	Microsurgical management of pediatric intracranial aneurysms 2010 ·Child s Nervous System ·Nader Sanai, Kurtis I. Auguste, Michael T. Lawton	33
19	Functional Outcome after Language Mapping for Glioma Resection breakdown → 2008 ·New England Journal of Medicine ·Nader Sanai, Zaman Mirzadeh, Mitchel S. Berger	748
20	Cellular composition and cytoarchitecture of the adult human subventricular zone: A niche of neural stem cells 2005 ·The Journal of Comparative Neurology ·Alfredo Quiñones‐Hinojosa, Nader Sanai, Mario Soriano‐Navarro, Óscar González-Pérez, Zaman Mirzadeh, Sara Gil‐Perotín, (unknown), Mitchel S. Berger, José Manuel García‐Verdugo, Arturo Álvarez-Buylla	435

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact